Chemoinformaics analysis of (Z)-3-(4-HYDROXY-3,5-DIMETHOXYPHENYL)PROP-2-ENOIC ACID
| Molecular Weight | 224.212 | nRot | 4 |
| Heavy Atom Molecular Weight | 212.116 | nRig | 8 |
| Exact Molecular Weight | 224.068 | nRing | 1 |
| Solubility: LogS | -2.234 | nHRing | 0 |
| Solubility: LogP | 1.572 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 30.3815 |
| nHD | 2 | BPOL | 16.3785 |
| QED | 0.758 |
| Synth | 1.977 |
| Natural Product Likeliness | 0.76 |
| NR-PPAR-gamma | 0.829 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.04 |
| HIA | 0.165 |
| CACO-2 | -4.962 |
| MDCK | 0.0000126 |
| BBB | 0.271 |
| PPB | 0.88799 |
| VDSS | 0.45 |
| FU | 0.0938904 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.833 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.277 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.198 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.084 |
| CL | 7.776 |
| T12 | 0.933 |
| hERG | 0.018 |
| Ames | 0.016 |
| ROA | 0.321 |
| SkinSen | 0.949 |
| Carcinogencity | 0.278 |
| EI | 0.94 |
| Respiratory | 0.428 |
| NR-Aromatase | 0.393 |
| Antiviral | No |
| Prediction | 0.65034 |